Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 838 results for "Novartis Company"

Novartis launches smartwatch navigation app for the visually impaired
Mobihealthnews

Spinifex to be acquired by Novartis

Australian pain drug innovation company sold to Novartis for US$200m plus milestone payments Spinifex Pharmaceuticals, Inc. and its Australian subsidiary Spinifex Pharmaceuticals Pty Ltd, a company focused on the development of new drugs for the ... Bionity.com, 2 days ago
Spinifex Pharmaceuticals sold to Novartis Manufacturing Chemist, 13 hours ago
Novartis buys drug firm Spinifex The Nation Nigeria, 1 day ago
[x]  

96 images for Novartis Company

Investing.com, 3 days ago
Business Insider, 3 days ago
Business Insider, 5 days ago
XinMsn, 5 days ago
Reuters, 5 days ago
Philly.com, 5 days ago
News-Times, 4 days ago
Bio Spectrum Asia, 2 days ago
Pharma Letter, 2 weeks ago
Pharma Letter, 2 days ago
Tech Times

New and Generic Drug Approvals: Prevacid 24 Hr

Drug Name(s) PREVACID 24 HR FDA Application No. (NDA) 022327 Active Ingredient(s) LANSOPRAZOLE Company NOVARTIS Original Approval or Tentative Approval Date May 18, 2009 Chemical Type ...
 U.S. Food and Drug Administration2 days ago US Wants Novartis To Pay $3.35 Billion Fine For Drug Kickbacks  Tech Times1 day ago U.S. seeks up to $3.35 billion in Novartis kickback lawsuit  CNBC3 days ago Novartis AG (ADR) Says Cosentyx Can Be A $5 Billion Drug After New Trial Data  Bidness Etc4 days ago
[x]  

Novartis AG (ADR) (NVS) To Acquire Spinifex For $200 Million

Novartis AG ADR ( NYSE:NVS ) has agreed to acquire Spinifex Pharmaceuticals, a US-Australian pain management biotech company, to strengthen its position in the pain management market, according to separate statements released by both companies ...
 Bidness Etc4 days ago Novartis To Acquires Australia's Spinifex Pharmaceutical - Quick Facts  RTTNews.com5 days ago
Arabstoday.net

Novartis: No. 1 pharma company in the world now and in 2020, says Evaluate Pharma

Market-data firm estimates overall 2020 global drug sales at
 Pharmaceutical Commerce1 week ago Global pharma firms grilled about tax in Australia  Manila Times1 day ago
[x]  
Reuters

INTERVIEW-Novartis to test new pricing model with heart failure drug

Novartis' head of pharmaceuticals David Epstein said that the company plans to utilise a new pricing model for some customers when the heart failure therapy Entresto is launched, as reported CNBC Tuesday. Specifically, Epstein suggested that some ...
 FirstWord Pharma3 days ago Novartis to Test New Pricing Model for Heart Failure Drug Entresto (Valsartan/Sacubitril)  P&T Community3 days ago REUTERS - INTERVIEW-Novartis to test new pricing model with heart failure drug  Namibia Press Agency3 days ago
[x]  
Topix

Switzerland's Novartis Buys US Biotech Firm Spinifex

Swiss drug manufacturer Novartis says it is buying Spinifex Pharmaceuticals, a U.S.-based biotechnology company that specializes in developing treatments for chronic pain. Novartis didn't disclose financial details Monday of the agreement to buy ...
 ABC News4 days ago Switzerland's Novartis buys US-based biotech firm Spinifex Pharmaceuticals for undisclosed sum  Yahoo! Canada4 days ago Novartis Buys Drug Development Company Spinifex Pharmaceuticals  Swissquote5 days ago Novartis : Switzerland's Novartis buys US-based biotech firm Spinifex Pharmaceuticals for undisclosed sum  4 Traders4 days ago
[x]  
InsiderMonkey.com

11 Biggest Generic Drug Companies in the World

When it comes to one can say that the list hasn't changed a great deal over the years. Names like Novartis, Johnson & Johnsons, Pfizer and Roche are still up there as the very best but in the last few years the bottom of the rankings have seen some ...
 InsiderMonkey.com6 days ago Sumeet Salwan to head Johnson & Johnson's global human resource  Economic Times1 month ago
Business Standard

Novartis India plunges 13% on denial to delising buzz

Shares of Novartis India slipped 13 percent intraday Friday after the company denied any delisting buzz. However, in previous session, the stock rallied 16 percent on reports that the parent company may delist its Indian unit.
 Money Control3 weeks ago Novartis India slumps 8% on clarification of de-listing plans  Business Standard3 weeks ago Novartis India has not received any notice from Novartis AG on delisting plans  India Infoline3 weeks ago Novartis India slumps after issuing clarification regarding delisting buzz  Business Standard3 weeks ago
[x]  

Novartis India Q4 net up 2 folds at Rs 51.94 cr

During the quarter under review, the company said its core pharmaceutical business recorded a total income of Rs 144.4 crore as against Rs 137.7 crore in the year-ago period.
 Money Control1 month ago
Business Standard

Patent refused to Novartis on anti-diabetes formulation

The Patent Office (PO) in Delhi, has refused to grant a patent to Novartis, the Swiss pharmaceutical company, for a modified release formulation of its diabetes drug, Vildagliptin, which it markets under the brand name of Galvus. Novartis has been engaged in ...
 Business Standard1 month ago US co Abraxis denied patent on cancer drug  Times of India1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less